Tag: inotuzumab ozogamicin
Pfizer’s blood cancer drug inotuzumab ozogamicin gets FDA priority review
Pfizer’s blood cancer drug, inotuzumab ozogamicin has secured a priority review designation from the US Food and Drug Administration (FDA). Inotuzumab ozogamicin has been developed ... Read More